Aarey Drugs and Pharmaceuticals

Intimation for closure of trading window

26 Mar, 2026 | 02:07pm • Source: BSE

Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to...

04 Feb, 2026 | 04:59pm • Source: BSE

Certificate under reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018

14 Jan, 2026 | 06:32pm • Source: BSE

Intimation for Closure of Trading Window

30 Dec, 2025 | 12:31pm • Source: BSE

Certificate under regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter and half year ended 30th September, 2025

08 Oct, 2025 | 02:28pm • Source: BSE

Disclosure on Voting Results along with Consolidated Scrutinizers Report of 35th Annual General Meeting of the Company

01 Oct, 2025 | 07:55pm • Source: BSE

Closure of Trading Window for the Quarter and half year ended 30 September, 2025

29 Sep, 2025 | 08:19pm • Source: BSE

AGM Proceedings of the 35th Annual General Meeting of the Company

29 Sep, 2025 | 06:40pm • Source: BSE

Corrigendum to the integrated Annual Report for FY 2024-25

24 Sep, 2025 | 05:09pm • Source: BSE

Newspaper Publication

12 Sep, 2025 | 06:49pm • Source: BSE

With reference to the Outcome submitted yesterday i.e., on 03.09.2025 we would like to clarify that due to inadvertent error in Point No. 2 of...

04 Sep, 2025 | 08:25pm • Source: BSE

Please find enclosed Disclosure

03 Sep, 2025 | 08:15pm • Source: BSE

Pursuant to Regulation 30 (read with Part A of Schedule 1ll) and Regulation 33 of the SEBI (ListingObligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"),...

03 Sep, 2025 | 08:10pm • Source: BSE

Newspaper Publication

18 Aug, 2025 | 04:39pm • Source: BSE

Unaudited Financial Results for the quarter ended 30th June, 2025 along with the Limited Review Report, MD/CFO Certificate

13 Aug, 2025 | 05:41pm • Source: BSE

Outcome of Board Meeting held on today i.e 13th August, 2025

13 Aug, 2025 | 05:33pm • Source: BSE

Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to...

07 Aug, 2025 | 01:08pm • Source: BSE

Revised filing of Audited Financial Results for the year ended 31st March, 2025

30 Jul, 2025 | 07:08pm • Source: BSE

Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for quarter ended 30th June, 2025

11 Jul, 2025 | 11:39am • Source: NSE

Certificate under Regulation 74(5) of SEBI (Depositories And Participants) Regulations, 2018 for the quarter ended 30th June, 2025

10 Jul, 2025 | 06:20pm • Source: BSE